Comparison of Human Serum with Fetal Bovine Serum for Expansion and Differentiation of Human Synovial MSC: Potential Feasibility for Clinical Applications
Abstract:The aim of this study was to evaluate the effect of human serum (HS) on growth and differentiation capacity of human synovium-derived mesenchymal stem cells (MSC) in comparison to cells grown in fetal bovine serum (FBS). Human MSCs were isolated from the synovium of knee joints of three donors and the cells were cultured individually in varying concentrations of allogenic HS or FBS. Bovine MSCs were isolated from synovium and cultured in the same manner. Cell proliferation was assessed by the tetrazolium assay… Show more
“…34,35 An in vitro chondrogenesis assay of rat MSCs demonstrated that pellets derived from synovium had superior chondrogenic potential, 36 which they retained chondrogenic potential only after a few passages. Tateishi et al 37 demonstrated allogenic human serum is superior for culture of human synovium-derived MSCs in terms of cellular expandability without losing chondrogenic differentiation capacity, though the underlying mechanisms remained unknown.…”
We undertook this study to characterize changes in the proliferative capacities, chondrogenic phenotypes, and gene expression profiles of human synovium-derived progenitor cells from osteoarthritic patients during in vitro expansion. Cells isolated from osteoarthritic synovia were cultured, and growth rates during serial passages were evaluated. Surface molecule expressions were determined by flow cytometry and cytogenetic analyses were performed. After chondrogenic differentiation in cell pellets, we evaluated type II collagen and glycosaminoglycan (GAG) synthesis. To assess whether the in vitro expansion of synovium-derived cells affects gene expression, we performed microarray analyses on cells at passage 0, 1, 2, 4, 6, and 8. Synovium-derived cells were rapidly expanded in vitro through passage 8 (about 130 days), and after passage 6, the proliferation rates decreased slightly with a wide range of individual variations. The expressions of CD166, CD49a, and CD106 decreased, whereas those of CD10, CD29, CD44, CD73, CD90, and CD105 showed no significant change. Karyotype analysis revealed no evidence of chromosome abnormalities. The staining of type II collagen and GAG in differentiated cell pellets showed rapid weakening. Genome-wide microarray analysis showed that synovium-derived cells from late passages over-expressed genes associated with cell cycle prolongation and cell aging, and less-expressed genes associated with cell growth stimulation. The in vitro expansion of synovium-derived cells was accompanied with decreased proliferative capacity and the chondrogenic phenotype, which might be modulated by change in gene expression patterns. ß
“…34,35 An in vitro chondrogenesis assay of rat MSCs demonstrated that pellets derived from synovium had superior chondrogenic potential, 36 which they retained chondrogenic potential only after a few passages. Tateishi et al 37 demonstrated allogenic human serum is superior for culture of human synovium-derived MSCs in terms of cellular expandability without losing chondrogenic differentiation capacity, though the underlying mechanisms remained unknown.…”
We undertook this study to characterize changes in the proliferative capacities, chondrogenic phenotypes, and gene expression profiles of human synovium-derived progenitor cells from osteoarthritic patients during in vitro expansion. Cells isolated from osteoarthritic synovia were cultured, and growth rates during serial passages were evaluated. Surface molecule expressions were determined by flow cytometry and cytogenetic analyses were performed. After chondrogenic differentiation in cell pellets, we evaluated type II collagen and glycosaminoglycan (GAG) synthesis. To assess whether the in vitro expansion of synovium-derived cells affects gene expression, we performed microarray analyses on cells at passage 0, 1, 2, 4, 6, and 8. Synovium-derived cells were rapidly expanded in vitro through passage 8 (about 130 days), and after passage 6, the proliferation rates decreased slightly with a wide range of individual variations. The expressions of CD166, CD49a, and CD106 decreased, whereas those of CD10, CD29, CD44, CD73, CD90, and CD105 showed no significant change. Karyotype analysis revealed no evidence of chromosome abnormalities. The staining of type II collagen and GAG in differentiated cell pellets showed rapid weakening. Genome-wide microarray analysis showed that synovium-derived cells from late passages over-expressed genes associated with cell cycle prolongation and cell aging, and less-expressed genes associated with cell growth stimulation. The in vitro expansion of synovium-derived cells was accompanied with decreased proliferative capacity and the chondrogenic phenotype, which might be modulated by change in gene expression patterns. ß
“…The use of mesenchymal stem cells (MSC) is an attractive option as these cells have a long lifespan and are not fully differentiated, suggesting that they could be tolerated from one individual to another. The use of human serum instead of serum of animal source, seems to have a direct and a positive effect on the phenotype of human synovium-derived mesenchymal stem cells (MSC), (Tateishi et al, 2008). The results of this study indicated that human serum (HS) is superior for the culture of human MSCs compared with fetal bovine serum (FBS) in terms of cellular expandability, without losing chondrogenic or osteogenic differentiation capacity.…”
Section: Cell-seeded (Stem Cells Autologous Cell Sources) or Acellulmentioning
“…FBS, which contains a pool of undetermined factors and components, caused the differentiation of BCSCs. Although FBS is an essential component of cell culture medium, it has been shown to cause differentiation of certain kinds of stem cells such as neural and embryonic, as well as germ cells (Bettiol et al, 2007;Franke et al, 2014;Hung and Young, 2006;Tateishi et al, 2008;Zahir et al, 2009). …”
Section: Discussionmentioning
confidence: 99%
“…In some recent publications, oxygen concentration has been shown to also affect drug resistance (Crowder et al, 2014;Samanta et al, 2014) and stemness of BCSCs (Mimeault and Batra, 2013;van den Beucken et al, 2014). Therefore, in this study we investigated the effects of components of media (FBS and growth factors) and oxygen concentration on spontaneous differentiation of BCSCs in vitro.…”
Abstract-Breast cancer is said to originate from breast cancer stem cells (BCSCs). Previous published studies showed that BCSCsexhibited a high degree of multi-drug resistance. This study aimed to evaluate the spontaneous differentiation of human BCSCs and investigate various in vitro conditions that could be used to control this process. BCSCs were sorted from primary cultures of breast malignant tumors based on expression of CD44 and CD24. The in vitro spontaneous differentiation of BCSCs was evaluated using standard DMEM/F12 medium supplemented with 10% fetal bovine serum (FBS) and 1% antibiotic-antimycotic. There were six different methods tried to control the spontaneous differentiation of BCSCs including culturing in serum-free medium, mammosphere medium, basic fibroblast growth factor and epidermal growth factor supplemented medium with serum, and culturing under hypoxic conditions. The results showed that BCSCs always spontaneously differentiated in vitro in standard DMEM/F12 plus 10% FBS culture medium. All investigated culture conditions could not completely inhibit the spontaneous differentiation of BCSCs. Serum-free culture medium under hypoxic conditions (mammosphere culture) had the strongest inhibitory effect on this process. These results demonstrated that spontaneous differentiation is a natural process of BCSCs; therefore this process may be somewhat controlled depending on the culture conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.